|
G |
Aars1 |
alanyl-tRNA synthetase 1 |
decreases expression increases expression |
ISO |
4-phenylbutyric acid results in decreased expression of AARS1 mRNA 4-phenylbutyric acid results in increased expression of AARS1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of ACSL4 protein] |
CTD |
PMID:36700298 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of ACTA2 mRNA |
CTD |
PMID:30481203 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ADAM17 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ADAM17 protein] |
CTD |
PMID:27638906 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [AGT protein results in increased cleavage of SREBF1 protein]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of FN1 protein]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of SREBF1 mRNA]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:25398788 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ahsa1 |
activator of Hsp90 ATPase activity 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of AHSA1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
|
|
G |
Ajuba |
ajuba LIM protein |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of AJUBA mRNA |
CTD |
PMID:14583596 |
|
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of AKR1C1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of AKT1 protein]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]] 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased phosphorylation of AKT1 protein] 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:25398788 PMID:28245985 PMID:31298478 PMID:32283200 PMID:36640941 PMID:37148176 More...
|
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT2 protein] |
CTD |
PMID:36640941 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Akt3 |
AKT serine/threonine kinase 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of AKT3 protein] |
CTD |
PMID:36640941 |
|
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
|
|
G |
Alpi |
alkaline phosphatase, intestinal |
multiple interactions |
ISO |
ALPI protein inhibits the reaction [4-phenylbutyric acid results in increased phosphorylation of NFE2L2 protein] |
CTD |
PMID:32407927 |
|
NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
EXP |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of APAF1 protein] 4-phenylbutyric acid results in decreased expression of APAF1 protein |
CTD |
PMID:33651226 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
App |
amyloid beta precursor protein |
affects activity |
EXP |
4-phenylbutyric acid affects the activity of APP protein |
CTD |
PMID:16204253 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions decreases expression |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased phosphorylation of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of ATF4 protein] 4-phenylbutyric acid results in decreased expression of ATF4 protein 4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Leflunomide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [perhexiline maleate results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of ATF4 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of ATF4 protein]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of ATF4 protein] |
CTD |
PMID:27470132 PMID:27484784 PMID:27634458 PMID:28063906 PMID:28844859 PMID:28988120 PMID:29653943 PMID:30025493 PMID:30602124 PMID:30980806 PMID:31364909 PMID:32578922 PMID:33309543 PMID:33651226 PMID:34175825 PMID:35398186 PMID:35413383 PMID:35533795 PMID:36030031 PMID:36473502 PMID:37741534 PMID:38065397 More...
|
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; [4-phenylbutyric acid co-treated with alpha-Chlorohydrin] results in decreased expression of ATF6 protein 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of ATF6 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; [4-phenylbutyric acid co-treated with Palmitic Acid] results in decreased expression of ATF6 protein 4-phenylbutyric acid results in decreased expression of ATF6 protein |
CTD |
PMID:20165829 PMID:26804720 PMID:27578021 PMID:27638906 PMID:28245985 PMID:30796460 PMID:30980806 PMID:31298478 PMID:31364909 PMID:33651226 PMID:34520753 PMID:35413383 PMID:36030031 PMID:36646296 PMID:37148176 PMID:37692514 PMID:38242296 More...
|
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atf6b |
activating transcription factor 6 beta |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of ATF6B protein] |
CTD |
PMID:34214594 |
|
NCBI chr20:4,090,921...4,098,920
Ensembl chr20:4,090,921...4,098,894
|
|
G |
Atg12 |
autophagy related 12 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 mRNA]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 protein] |
CTD |
PMID:34175825 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg3 |
autophagy related 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of ATG3 protein] |
CTD |
PMID:35398186 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
decreases expression multiple interactions |
ISO |
4-phenylbutyric acid results in decreased expression of ATG4B protein 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of ATG4B protein] |
CTD |
PMID:36640941 |
|
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
|
|
G |
Atg5 |
autophagy related 5 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATG5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATG5 protein] |
CTD |
PMID:34175825 PMID:37654027 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions increases expression |
ISO EXP |
4-phenylbutyric acid results in decreased expression of BAX protein 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of BAX protein] 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of BAX protein]] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of BAX protein]]; 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of BAX protein] 4-phenylbutyric acid results in increased expression of BAX protein |
CTD |
PMID:25450231 PMID:27816613 PMID:29306025 PMID:30980806 PMID:31364909 PMID:33651226 PMID:33771661 PMID:34214594 PMID:37148176 PMID:38065397 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BBC3 protein] |
CTD |
PMID:34214594 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Silver Compounds results in decreased expression of BCL2 protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein] 4-phenylbutyric acid results in increased expression of BCL2 protein 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in decreased expression of BCL2 protein] |
CTD |
PMID:27816613 PMID:29306025 PMID:33651226 PMID:34214594 PMID:38065397 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of BCL2L11 protein] |
CTD |
PMID:34214594 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of BCL6 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [Ethylmercury Compounds results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of BECN1 protein]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of BECN1 protein] 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of BECN1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of BECN1 protein] 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of BECN1 protein] |
CTD |
PMID:27511942 PMID:33127495 PMID:35398186 PMID:36058351 PMID:36700298 PMID:37654027 PMID:38065397 More...
|
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of BIRC5 mRNA |
CTD |
PMID:30481203 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of BNIP3 protein] |
CTD |
PMID:33127495 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Camkk2 |
calcium/calmodulin-dependent protein kinase kinase 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of CAMKK2 protein] |
CTD |
PMID:33651226 |
|
NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279
|
|
G |
Capn2 |
calpain 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [honokiol results in increased expression of CAPN2 protein] |
CTD |
PMID:34973135 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
decreases expression increases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CARS1 mRNA 4-phenylbutyric acid results in increased expression of CARS1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP1 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of CASP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein] 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased activity of CASP1 protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 PMID:37654027 PMID:37692514 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of CASP12 protein]]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased activity of CASP12 protein] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased cleavage of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of CASP12 protein]; 4-phenylbutyric acid results in increased expression of and results in decreased cleavage of CASP12 protein 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased degradation of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased cleavage of CASP12 protein] |
CTD |
PMID:17459145 PMID:27638049 PMID:28245985 PMID:33651226 PMID:33771661 PMID:33922211 PMID:36646296 More...
|
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Cyclosporine results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP3 protein] 4-phenylbutyric acid results in decreased expression of CASP3 protein 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased activity of and results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP3 protein]]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of CASP3 protein modified form] |
CTD |
PMID:21804221 PMID:24865413 PMID:25450231 PMID:25870318 PMID:27578021 PMID:27638049 PMID:27638906 PMID:29306025 PMID:29981725 PMID:30980806 PMID:31364909 PMID:32407927 PMID:32569804 PMID:32879258 PMID:33651226 PMID:33771661 PMID:33922211 PMID:34214594 PMID:35033536 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP7 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP7 protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein]]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein] |
CTD |
PMID:24865413 PMID:25870318 PMID:33771661 PMID:33922211 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Ficusin results in increased activity of CASP8 protein] |
CTD |
PMID:31364909 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased cleavage of CASP9 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of CASP9 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of CASP9 protein modified form] |
CTD |
PMID:29306025 PMID:32569804 PMID:33651226 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
4-phenylbutyric acid results in decreased expression of CCL2 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CCL2 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CCL2 mRNA] |
CTD |
PMID:28698385 PMID:35413383 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CCNB1 protein] |
CTD |
PMID:36058351 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
4-phenylbutyric acid promotes the reaction [[2,3,5-trichloro-6-phenyl-(1,4)benzoquinone co-treated with malondialdehyde-low density lipoprotein, human] results in increased expression of CD36 mRNA] |
CTD |
PMID:32434321 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cdc25c |
cell division cycle 25C |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDC25C protein] |
CTD |
PMID:36058351 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [ochratoxin A results in decreased expression of CDK1 protein] |
CTD |
PMID:36058351 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
[4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN1A mRNA 4-phenylbutyric acid results in increased expression of CDKN1A protein |
CTD |
PMID:17210717 PMID:23770000 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions |
ISO |
[4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN2A mRNA |
CTD |
PMID:17210717 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [honokiol results in decreased activity of CEBPB protein] |
CTD |
PMID:34973135 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions increases activity |
ISO |
4-phenylbutyric acid results in increased activity of and affects the localization of CFTR protein mutant form; 4-phenylbutyric acid results in increased stability of and affects the localization of CFTR protein 4-phenylbutyric acid results in increased activity of CFTR protein mutant form |
CTD |
PMID:14583596 PMID:15191910 PMID:15880796 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of CIDEC mRNA] |
CTD |
PMID:28962527 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CITED2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CLDN1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn11 |
claudin 11 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of CLDN11 protein] |
CTD |
PMID:35533795 |
|
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
|
|
G |
Cmss1 |
cms1 ribosomal small subunit homolog |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CMSS1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr11:42,934,390...43,232,624
Ensembl chr11:42,934,440...43,232,624
|
|
G |
Cnih4 |
cornichon family member 4 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CNIH4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:92,910,315...92,926,428
Ensembl chr13:92,910,315...92,927,853
|
|
G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CNOT2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:52,130,445...52,222,338
Ensembl chr 7:52,130,441...52,223,575
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased expression of COL10A1 protein] |
CTD |
PMID:29653943 |
|
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of COL5A1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in decreased expression of COX4I1 protein] |
CTD |
PMID:36473502 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Csde1 |
cold shock domain containing E1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of CSDE1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:190,546,015...190,582,787
Ensembl chr 2:190,554,980...190,582,784
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CSF1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CSF2 protein] |
CTD |
PMID:35413383 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CSF3 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of CSPG5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 8:110,220,506...110,234,766
Ensembl chr 8:110,220,653...110,234,758
|
|
G |
Cst3 |
cystatin C |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and affects the localization of CST3 protein] |
CTD |
PMID:33651226 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of CTSD protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CTSD protein] |
CTD |
PMID:27638906 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of CYCS protein]; 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in increased expression of CYCS protein] |
CTD |
PMID:29306025 PMID:37741534 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions decreases expression decreases phosphorylation |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased phosphorylation of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Cyclosporine results in increased expression of and affects the localization of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [discretamine results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and affects the localization of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Leflunomide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [nefazodone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [perhexiline maleate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DDIT3 protein]] 4-phenylbutyric acid results in decreased expression of DDIT3 protein 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased phosphorylation of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Oxygen deficiency results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [anandamide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of DDIT3 protein]; 4-phenylbutyric acid promotes the reaction [Palmitic Acid results in increased expression of DDIT3 mRNA] 4-phenylbutyric acid results in decreased phosphorylation of DDIT3 protein |
CTD |
PMID:24053669 PMID:24865413 PMID:25295624 PMID:25450231 PMID:26513129 PMID:26804720 PMID:27470132 PMID:27484784 PMID:27578021 PMID:27613715 PMID:27634458 PMID:27638049 PMID:27816613 PMID:28063906 PMID:28245985 PMID:28698385 PMID:28844859 PMID:28988120 PMID:29653943 PMID:29981725 PMID:30025493 PMID:30602124 PMID:30980806 PMID:31298478 PMID:31364909 PMID:31891755 PMID:32407927 PMID:32578922 PMID:32590070 PMID:32879258 PMID:33309543 PMID:33651226 PMID:33677747 PMID:33771661 PMID:33922211 PMID:34214594 PMID:34958886 PMID:35033536 PMID:35398186 PMID:35413383 PMID:35533795 PMID:36030031 PMID:36646296 PMID:37654027 PMID:37741534 PMID:38065397 PMID:38242296 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddx55 |
DEAD-box helicase 55 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of DDX55 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr12:32,034,462...32,050,218
Ensembl chr12:32,034,462...32,050,219
|
|
G |
Derl1 |
derlin 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of DERL1 protein] |
CTD |
PMID:30980806 |
|
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of DGAT1 mRNA] |
CTD |
PMID:36670177 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of DNAJB9 mRNA] 4-phenylbutyric acid results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:28698385 PMID:28962527 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnm1l |
dynamin 1-like |
increases phosphorylation multiple interactions |
ISO EXP |
4-phenylbutyric acid results in increased phosphorylation of DNM1L protein 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and affects the localization of DNM1L protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased phosphorylation of DNM1L protein] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of DNM1L protein] |
CTD |
PMID:33651226 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of EDEM1 mRNA] 4-phenylbutyric acid results in decreased expression of EDEM1 mRNA |
CTD |
PMID:23274897 PMID:28698385 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Eef1e1 |
eukaryotic translation elongation factor 1 epsilon 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of EEF1E1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:26,148,652...26,159,358
Ensembl chr17:26,148,633...26,215,720
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of EFTUD2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:87,804,893...87,852,181
Ensembl chr10:87,804,892...87,846,079
|
|
G |
Egfl7 |
EGF-like-domain, multiple 7 |
increases expression multiple interactions |
ISO |
4-phenylbutyric acid results in increased expression of EGFL7 mRNA alternative form [decitabine co-treated with 4-phenylbutyric acid] results in increased expression of EGFL7 mRNA alternative form |
CTD |
PMID:19116145 |
|
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
|
|
G |
Ehd3 |
EH-domain containing 3 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of EHD3 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF2A protein]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased phosphorylation of EIF2A protein] 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of EIF2A mRNA] 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein] |
CTD |
PMID:31364909 PMID:34175825 PMID:38242296 PMID:38604440 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases expression multiple interactions |
EXP ISO |
4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2AK3 protein modified form] 4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of EIF2AK3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of EIF2AK3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased phosphorylation of EIF2AK3 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form] 4-phenylbutyric acid results in decreased expression of EIF2AK3 protein; 4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:27470132 PMID:27484784 PMID:27638906 PMID:28063906 PMID:28245985 PMID:29653943 PMID:30796460 PMID:31364909 PMID:32569804 PMID:33651226 PMID:34175825 PMID:35533795 PMID:36005737 PMID:36646296 PMID:37654027 PMID:37692514 PMID:37741534 PMID:38065397 PMID:38604440 More...
|
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Atorvastatin results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid results in decreased expression of and results in increased phosphorylation of EIF2S1 protein 4-phenylbutyric acid results in decreased expression of EIF2S1 protein modified form 4-phenylbutyric acid affects the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of EIF2S1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of EIF2S1 protein modified form] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of EIF2S1 mRNA]; 4-phenylbutyric acid inhibits the reaction [anandamide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of EIF2S1 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:20876807 PMID:25295624 PMID:26513129 PMID:26804720 PMID:27484784 PMID:27638049 PMID:27638906 PMID:28063906 PMID:28844859 PMID:29653943 PMID:30602124 PMID:33651226 PMID:34214594 PMID:34520753 PMID:35413383 PMID:35533795 PMID:36670177 More...
|
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions decreases expression increases expression |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of ERN1 protein modified form] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of and results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Asbestos, Amosite results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Hydrogen Peroxide results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of ERN1 protein] 4-phenylbutyric acid results in decreased expression of ERN1 protein 4-phenylbutyric acid results in increased expression of ERN1 protein 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ERN1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein]; 4-phenylbutyric acid promotes the reaction [Palmitic Acid results in increased expression of ERN1 mRNA] |
CTD |
PMID:20399799 PMID:23885834 PMID:29444456 PMID:30796460 PMID:33651226 PMID:34520753 PMID:35413383 PMID:36030031 PMID:36646296 PMID:37692514 PMID:38242296 PMID:38604440 More...
|
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Faah |
fatty acid amide hydrolase |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of FAAH mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Farsb |
phenylalanyl-tRNA synthetase subunit beta |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of FARSB mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of FASN mRNA] 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of FASN mRNA] |
CTD |
PMID:32407927 PMID:36670177 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of FBLN1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] |
CTD |
PMID:30980806 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of FGF2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fis1 |
fission, mitochondrial 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of FIS1 protein] |
CTD |
PMID:33651226 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
multiple interactions |
ISO |
4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of FKBP11 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:25398788 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in decreased expression of FOXO1 protein] |
CTD |
PMID:36030031 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of FOXO3 protein] 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in decreased phosphorylation of FOXO3 protein] |
CTD |
PMID:33127495 PMID:34214594 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of GAS5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gas6 |
growth arrest specific 6 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of GAS6 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of GJA1 protein] |
CTD |
PMID:35533795 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of GPD2 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of GPT protein] 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased activity of GPT protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of GPT protein] 4-phenylbutyric acid inhibits the reaction [TAK-875 results in increased expression of GPT protein]; 4-phenylbutyric acid inhibits the reaction [triptolide results in increased expression of GPT protein] |
CTD |
PMID:27470132 PMID:28063906 PMID:28844859 PMID:30243991 PMID:36520315 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of GPX3 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in decreased expression of GPX4 protein] |
CTD |
PMID:36700298 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of GRB10 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of GSDMD mRNA] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of GSDMD protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of GSDMD protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of GSTA4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[4-phenylbutyric acid affects the acetylation of HDAC1 protein] which affects the expression of TUBB3 protein |
CTD |
PMID:18497984 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac3 |
histone deacetylase 3 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [honokiol results in decreased expression of HDAC3 protein] |
CTD |
PMID:34973135 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression multiple interactions |
EXP |
4-phenylbutyric acid results in increased expression of HGF mRNA; 4-phenylbutyric acid results in increased expression of HGF protein 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of HGF protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in decreased expression of HGF mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in decreased expression of HGF protein] |
CTD |
PMID:28844859 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hk2 |
hexokinase 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HK2 protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of HMGA1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HMGA2 protein] 4-phenylbutyric acid results in decreased expression of HMGA2 protein |
CTD |
PMID:36473502 |
|
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of HNRNPC mRNA |
CTD |
PMID:14583596 |
|
NCBI chr15:24,779,593...24,809,213
Ensembl chr15:24,779,450...24,809,183
|
|
G |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HS6ST mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 9:38,283,502...38,322,684
Ensembl chr 9:38,282,395...38,322,683
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPA1A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa2 |
heat shock protein family A (Hsp70) member 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPA2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
|
|
G |
Hspa4l |
heat shock protein family A (Hsp70) member 4 like |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPA4L mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions decreases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of HSPA5 protein]]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [[2,3,5-trichloro-6-phenyl-(1,4)benzoquinone co-treated with malondialdehyde-low density lipoprotein, human] results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Mercuric Chloride results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 protein] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cantharidin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [discretamine results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [fumonisin B1 results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Rifampin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [tributyltin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]]; Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in increased expression of HSPA5 protein]]; mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of HSPA5 protein] 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Pyrazinamide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [tetrachlorobenzoquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA] |
CTD |
PMID:17459145 PMID:20165829 PMID:23743301 PMID:25295624 PMID:26804720 PMID:27470132 PMID:27484784 PMID:27578021 PMID:27638049 PMID:27816613 PMID:28063906 PMID:28245985 PMID:28698385 PMID:28844859 PMID:29981725 PMID:30602124 PMID:30980806 PMID:31298478 PMID:31364909 PMID:31891755 PMID:32407927 PMID:32434321 PMID:32569804 PMID:32590070 PMID:32879258 PMID:33677747 PMID:33771661 PMID:33922211 PMID:34958886 PMID:35297523 PMID:35398186 PMID:35413383 PMID:35533795 PMID:36005737 PMID:36030031 PMID:36640941 PMID:36646296 PMID:37148176 PMID:37654027 PMID:37741534 PMID:38065397 PMID:38242296 PMID:38604440 More...
|
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HSPH1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of ID1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IFNB1 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IFNB1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IFNG mRNA]; 4-phenylbutyric acid results in decreased expression of and results in decreased secretion of IFNG protein |
CTD |
PMID:35413383 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL10 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL10 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL17A protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL17A mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of IL18 mRNA] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of and results in increased secretion of IL18 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased secretion of IL18 protein] 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased secretion of IL18 protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 PMID:37654027 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1A protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL1A mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of CXCL8 mRNA]; 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL1B mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased cleavage of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein] 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] |
CTD |
PMID:17709599 PMID:28245985 PMID:30796460 PMID:35297523 PMID:35413383 PMID:36646296 PMID:37654027 PMID:37692514 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of IL6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL6 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; 4-phenylbutyric acid inhibits the reaction [SR 1078 results in increased expression of IL6 protein] 4-phenylbutyric acid results in decreased expression of IL6 mRNA |
CTD |
PMID:17709599 PMID:28245985 PMID:28698385 PMID:35413383 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS1 protein results in increased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]] 4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS1 results in increased uptake of Deoxyglucose]] |
CTD |
PMID:20165829 PMID:32283200 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Glucosamine inhibits the reaction [INS results in increased uptake of Deoxyglucose]]; 4-phenylbutyric acid inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]] 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2A protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [[INS co-treated with Acrylamide] results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:20165829 PMID:32283200 PMID:38604440 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased phosphorylation of IRS1 protein] |
CTD |
PMID:31298478 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Kmt5b |
lysine methyltransferase 5B |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of KMT5B mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:201,000,444...201,049,819
Ensembl chr 1:201,000,444...201,049,819
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of LDHA protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
ISO |
4-phenylbutyric acid affects the reaction [LEPR gene mutant form affects the splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of GPD2 mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of MAFA mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of NKX6-1 mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PCX mRNA]; 4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PDX1 mRNA]; 4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of EDEM1 mRNA]; 4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of FKBP11 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Mafa |
MAF bZIP transcription factor A |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of MAFA mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
|
|
G |
Magea9 |
MAGE family member A9 |
multiple interactions |
ISO |
4-phenylbutyric acid affects the reaction [decitabine affects the expression of MAGEA9 mRNA]; 4-phenylbutyric acid affects the reaction [decitabine affects the expression of MAGEA9 protein] |
CTD |
PMID:17290406 |
|
NCBI chr X:142,619,282...142,624,654
Ensembl chr X:142,619,395...142,624,653
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [dibromoacetonitrile results in increased expression of and results in increased localization of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased lipidation of MAP1LC3B protein] 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased lipidation of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased lipidation of MAP1LC3B protein]; Curcumin inhibits the reaction [4-phenylbutyric acid results in decreased expression of MAP1LC3B protein] |
CTD |
PMID:26804720 PMID:30025493 PMID:36058351 PMID:36640941 PMID:36700298 PMID:37148176 PMID:37654027 PMID:37741534 PMID:38065397 More...
|
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
decreases expression multiple interactions |
ISO |
4-phenylbutyric acid results in decreased expression of MAP3K5 protein 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] |
CTD |
PMID:29444456 |
|
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK1 protein] 4-phenylbutyric acid results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:21147958 PMID:34520753 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK3 protein] 4-phenylbutyric acid results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:21147958 PMID:34520753 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK8 protein] 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of MAPK8 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK8 protein] 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:21147958 PMID:31364909 PMID:35413383 PMID:38242296 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:21147958 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MAT2A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
multiple interactions |
ISO |
[4-phenylbutyric acid affects the acetylation of MECP2 protein] which affects the expression of TUBB3 protein |
CTD |
PMID:18497984 |
|
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
|
|
G |
Mef2a |
myocyte enhancer factor 2a |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein] |
CTD |
PMID:20165829 |
|
NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of MET mRNA] |
CTD |
PMID:28844859 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mfn2 |
mitofusin 2 |
increases expression multiple interactions |
EXP ISO |
4-phenylbutyric acid results in increased expression of MFN2 protein 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in decreased expression of MFN2 protein] |
CTD |
PMID:33651226 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mief1 |
mitochondrial elongation factor 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MIEF1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:111,786,630...111,802,220
Ensembl chr 7:111,786,709...111,802,220
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased secretion of MPO protein] |
CTD |
PMID:35413383 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrps18c |
mitochondrial ribosomal protein S18C |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MRPS18C mRNA |
CTD |
PMID:14583596 |
|
NCBI chr14:8,812,301...8,818,538
Ensembl chr14:8,791,330...8,818,516
|
|
G |
Mrps22 |
mitochondrial ribosomal protein S22 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of MRPS22 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 8:99,184,110...99,197,278
Ensembl chr 8:99,184,109...99,197,291
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in decreased expression of ND1 protein] |
CTD |
PMID:36473502 |
|
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
ISO |
4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased phosphorylation of MTOR protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of MTOR protein] 4-phenylbutyric acid results in decreased phosphorylation of MTOR protein |
CTD |
PMID:28245985 PMID:36640941 PMID:37148176 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NCF1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NCF1 protein] |
CTD |
PMID:20399799 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of NCOA4 protein] |
CTD |
PMID:36700298 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G |
Nde1 |
nudE neurodevelopment protein 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NDE1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of NFE2L2 protein] ALPI protein inhibits the reaction [4-phenylbutyric acid results in increased phosphorylation of NFE2L2 protein] |
CTD |
PMID:20399799 PMID:32407927 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:28245985 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nifk |
nucleolar protein interacting with the FHA domain of MKI67 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NIFK mRNA |
CTD |
PMID:14583596 |
|
NCBI chr13:29,393,303...29,403,387
Ensembl chr13:29,393,286...29,405,896
|
|
G |
Nkx6-1 |
NK6 homeobox 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of NKX6-1 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr14:7,969,756...7,976,689
Ensembl chr14:7,969,756...7,976,681
|
|
G |
Nln |
neurolysin |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NLN mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:35,133,634...35,232,927
Ensembl chr 2:35,134,145...35,232,914
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of NLRP3 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of NLRP3 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein] 4-phenylbutyric acid inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NLRP3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of NLRP3 protein] 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 protein] |
CTD |
PMID:30796460 PMID:35297523 PMID:36646296 PMID:37654027 PMID:37692514 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NOLC1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088
|
|
G |
Nom1 |
nucleolar protein with MIF4G domain 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of NOM1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:5,891,220...5,910,741
Ensembl chr 4:5,892,909...5,909,709
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of NR1D2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Ocln |
occludin |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein] |
CTD |
PMID:35533795 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Ostn |
osteocrin |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of OSTN mRNA] |
CTD |
PMID:30602124 |
|
NCBI chr11:73,442,167...73,478,498
Ensembl chr11:73,442,487...73,468,603
|
|
G |
Padi2 |
peptidyl arginine deiminase 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of PADI2 mRNA |
CTD |
PMID:28698385 |
|
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
|
|
G |
Park7 |
Parkinsonism associated deglycase |
multiple interactions increases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of PARK7 protein] 4-phenylbutyric acid results in increased expression of PARK7 mRNA; 4-phenylbutyric acid results in increased expression of PARK7 protein [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Hydrogen Peroxide; [4-phenylbutyric acid results in increased expression of PARK7 protein] which results in decreased susceptibility to Oxidopamine |
CTD |
PMID:17459145 PMID:21372141 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Acrylamide results in increased cleavage of PARP1 protein]; 4-phenylbutyric acid inhibits the reaction [pendulone results in increased cleavage of PARP1 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in increased cleavage of PARP1 protein]; 4-phenylbutyric acid inhibits the reaction [thymoquinone results in increased cleavage of PARP1 protein] 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of PARP1 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of PARP1 protein modified form] 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased cleavage of PARP1 protein] |
CTD |
PMID:27578021 PMID:27634458 PMID:29981725 PMID:32407927 PMID:34214594 PMID:35288263 PMID:37741534 More...
|
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of PAWR mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pc |
pyruvate carboxylase |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PCX mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pdcd2l |
programmed cell death 2-like |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of PDCD2L mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:86,810,292...86,822,554
Ensembl chr 1:86,810,292...86,822,554
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [LEPR gene mutant form results in decreased expression of PDX1 mRNA] |
CTD |
PMID:23274897 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein] |
CTD |
PMID:37692514 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of PKM protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pole4 |
DNA polymerase epsilon 4, accessory subunit |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of POLE4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:115,165,285...115,171,097
Ensembl chr 4:115,165,285...115,171,097
|
|
G |
Polr1h |
RNA polymerase I subunit H |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of POLR1H mRNA |
CTD |
PMID:14583596 |
|
NCBI chr20:1,594,936...1,598,854
Ensembl chr20:1,594,936...1,598,854
|
|
G |
Polr2a |
RNA polymerase II subunit A |
increases expression decreases expression |
ISO |
4-phenylbutyric acid results in increased expression of POLR2A mRNA 4-phenylbutyric acid results in decreased expression of POLR2A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA] |
CTD |
PMID:36670177 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein] 4-phenylbutyric acid inhibits the reaction [Glucose results in decreased expression of PPARGC1A mRNA] |
CTD |
PMID:20165829 PMID:28482072 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppil1 |
peptidylprolyl isomerase like 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of PPIL1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr20:7,302,292...7,322,349
Ensembl chr20:7,302,621...7,322,354
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in increased expression of PTGS2 protein] |
CTD |
PMID:17709599 PMID:36700298 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of PYCARD mRNA] 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of PYCARD protein] |
CTD |
PMID:30796460 PMID:36646296 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rbm8a |
RNA binding motif protein 8A |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of RBM8A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:184,165,189...184,167,959
Ensembl chr 2:184,165,193...184,167,959
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [honokiol results in decreased expression of RELA protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:28245985 PMID:34973135 PMID:36646296 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rnf185 |
ring finger protein 185 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of RNF185 protein] |
CTD |
PMID:34958886 |
|
NCBI chr14:78,292,517...78,329,832
Ensembl chr14:78,292,516...78,329,864
|
|
G |
Rpl7a |
ribosomal protein L7A |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of RPL7A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:10,239,026...10,241,703
Ensembl chr 3:10,239,001...10,241,716
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of HLA-E mRNA |
CTD |
PMID:14583596 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
Sarnp |
SAP domain containing ribonucleoprotein |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SARNP mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:1,251,096...1,305,335
Ensembl chr 7:1,251,098...1,305,332
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of SESN2 mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of SESN2 protein] |
CTD |
PMID:32407927 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Sftpc |
surfactant protein C |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CASP3 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased cleavage of CTSD protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ADAM17 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased phosphorylation of EIF2S1 protein] |
CTD |
PMID:27638906 |
|
NCBI chr15:45,596,565...45,599,615
Ensembl chr15:45,596,574...45,610,777
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of ATF4 mRNA]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 mRNA]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [SIRT1 protein affects the phosphorylation of EIF2S1 protein] |
CTD |
PMID:29653943 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of SLC22A18 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of SLC2A1 protein] |
CTD |
PMID:32569804 PMID:36473502 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein] |
CTD |
PMID:20165829 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [arsenite results in increased expression of SLC38A2 mRNA] |
CTD |
PMID:22215663 |
|
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
|
|
G |
Slc44a2 |
solute carrier family 44 member 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of CTL2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 8:19,870,867...19,905,345
Ensembl chr 8:19,870,888...19,905,342
|
|
G |
Slc5a6 |
solute carrier family 5 member 6 |
multiple interactions increases expression |
ISO |
mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in increased expression of SLC5A6 protein] |
CTD |
PMID:36005737 |
|
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Particulate Matter results in decreased expression of SLC7A11 protein] |
CTD |
PMID:36700298 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slu7 |
SLU7 homolog, splicing factor |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SLU7 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:27,908,325...27,923,784
Ensembl chr10:27,908,396...27,923,349
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Rotenone results in increased expression of SNCA protein]; 4-phenylbutyric acid inhibits the reaction [SNCA protein binds to SNCA protein] |
CTD |
PMID:17459145 PMID:21372141 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Snx5 |
sorting nexin 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SNX5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 3:131,621,875...131,641,127
Ensembl chr 3:131,621,880...131,641,192
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [perfluorooctanoic acid results in increased expression of SOD1 mRNA]; [4-phenylbutyric acid co-treated with Thapsigargin] results in increased expression of SOD1 mRNA |
CTD |
PMID:32578922 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions increases expression |
EXP |
4-phenylbutyric acid inhibits the reaction [cobaltous chloride results in decreased expression of SOD3 mRNA] 4-phenylbutyric acid results in increased expression of SOD3 mRNA |
CTD |
PMID:21804221 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SOX4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in decreased expression of SQSTM1 protein]; 4-phenylbutyric acid inhibits the reaction [SC-66 compound results in decreased expression of SQSTM1 protein] 4-phenylbutyric acid results in increased expression of SQSTM1 protein |
CTD |
PMID:32569804 PMID:33127495 PMID:36640941 PMID:36700298 PMID:37741534 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
EXP ISO |
4-phenylbutyric acid inhibits the reaction [AGT protein results in increased cleavage of SREBF1 protein]; 4-phenylbutyric acid inhibits the reaction [AGT protein results in increased expression of SREBF1 mRNA] 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of SREBF1 mRNA] |
CTD |
PMID:25398788 PMID:36670177 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srsf10 |
serine and arginine rich splicing factor 10 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of SRSF10 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768
|
|
G |
Syvn1 |
synoviolin 1 |
decreases expression multiple interactions |
ISO EXP |
4-phenylbutyric acid results in decreased expression of SYVN1 mRNA 4-phenylbutyric acid inhibits the reaction [Streptozocin results in decreased expression of SYVN1 protein] |
CTD |
PMID:14583596 PMID:30980806 |
|
NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
|
|
G |
Tax1bp1 |
Tax1 binding protein 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TAX1BP1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:81,821,991...81,877,906
Ensembl chr 4:81,821,989...81,879,100
|
|
G |
Tax1bp3 |
Tax1 binding protein 3 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TAX1BP3 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
|
|
G |
Tg |
thyroglobulin |
multiple interactions |
ISO |
4-phenylbutyric acid inhibits the reaction [Amiodarone results in decreased expression of TG protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TG protein] |
CTD |
PMID:25295624 PMID:36005737 |
|
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TGFB1 protein |
CTD |
PMID:25450231 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Th |
tyrosine hydroxylase |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of TH protein |
CTD |
PMID:21372141 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Timm50 |
translocase of inner mitochondrial membrane 50 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TIMM50 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:83,574,872...83,582,748
Ensembl chr 1:83,556,757...83,582,793
|
|
G |
Tmed5 |
transmembrane p24 trafficking protein 5 |
increases expression decreases expression |
ISO |
4-phenylbutyric acid results in increased expression of TMED5 mRNA 4-phenylbutyric acid results in decreased expression of TMED5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr14:1,607,895...1,619,028
Ensembl chr14:1,607,819...1,628,426
|
|
G |
Tmpo |
thymopoietin |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TMPO mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of TNF protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of TNF mRNA]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of TNF mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; 4-phenylbutyric acid inhibits the reaction [SR 1078 results in increased expression of TNF protein] 4-phenylbutyric acid results in decreased expression of TNF mRNA |
CTD |
PMID:27578021 PMID:28245985 PMID:28698385 PMID:35413383 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of TP53 protein] |
CTD |
PMID:30980806 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tra2a |
transformer 2 alpha |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TRA2A mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
|
|
G |
Tsc2 |
TSC complex subunit 2 |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of TSC2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
|
|
G |
Tsr1 |
TSR1, ribosome maturation factor |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of TSR1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr10:59,760,420...59,771,868
Ensembl chr10:59,760,409...59,771,864
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
multiple interactions affects expression |
ISO |
[4-phenylbutyric acid affects the acetylation of HDAC1 protein] which affects the expression of TUBB3 protein; [4-phenylbutyric acid affects the acetylation of MECP2 protein] which affects the expression of TUBB3 protein; [decitabine co-treated with 4-phenylbutyric acid] affects the expression of TUBB3 protein 4-phenylbutyric acid affects the expression of TUBB3 protein |
CTD |
PMID:18497984 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UBA1 protein] |
CTD |
PMID:30980806 |
|
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
|
|
G |
Uba6 |
ubiquitin-like modifier activating enzyme 6 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of UBA6 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr14:21,884,039...21,947,857
Ensembl chr14:21,884,039...21,947,857
|
|
G |
Ube2d1 |
ubiquitin-conjugating enzyme E2D 1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Chlormequat results in increased expression of UBE2D1 protein] |
CTD |
PMID:34958886 |
|
NCBI chr20:17,309,315...17,343,770
Ensembl chr20:17,309,315...17,342,295
|
|
G |
Ube2w |
ubiquitin-conjugating enzyme E2W |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of UBE2W mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:2,690,742...2,754,491
Ensembl chr 5:2,690,763...2,814,965
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL1 protein] |
CTD |
PMID:30980806 |
|
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Uchl5 |
ubiquitin C-terminal hydrolase L5 |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL5 protein] |
CTD |
PMID:30980806 |
|
NCBI chr13:55,520,722...55,556,503
Ensembl chr13:55,520,729...55,556,502
|
|
G |
Umod |
uromodulin |
increases expression |
ISO |
4-phenylbutyric acid results in increased expression of UMOD protein; 4-phenylbutyric acid results in increased expression of UMOD protein mutant form |
CTD |
PMID:24567330 |
|
NCBI chr 1:173,816,341...173,829,681
Ensembl chr 1:173,816,339...173,830,302
|
|
G |
Utp4 |
UTP4 small subunit processome component |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of UTP4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr19:34,790,962...34,820,558
Ensembl chr19:34,792,457...34,820,550
|
|
G |
Vcp |
valosin-containing protein |
multiple interactions |
EXP |
4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of VCP protein] |
CTD |
PMID:30980806 |
|
NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression multiple interactions |
EXP |
4-phenylbutyric acid results in decreased expression of VEGFA protein 4-phenylbutyric acid inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of VEGFA mRNA]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of VEGFA mRNA]; 4-phenylbutyric acid inhibits the reaction [Thapsigargin results in increased expression of VEGFA protein]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of VEGFA mRNA]; 4-phenylbutyric acid inhibits the reaction [Tunicamycin results in increased expression of VEGFA protein] |
CTD |
PMID:28844859 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Wdr4 |
WD repeat domain 4 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of WDR4 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr20:9,587,205...9,611,434
Ensembl chr20:9,587,207...9,603,581
|
|
G |
Wwtr1 |
WW domain containing transcription regulator 1 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of WWTR1 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 2:141,651,159...141,766,919
Ensembl chr 2:141,648,108...141,766,968
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions decreases expression |
ISO EXP |
4-phenylbutyric acid inhibits the reaction [[Amiodarone results in increased splicing of XBP1 mRNA] which results in increased expression of XBP1 mRNA alternative form]; 4-phenylbutyric acid inhibits the reaction [Amiodarone results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of XBP1 protein alternative form] 4-phenylbutyric acid inhibits the reaction [alpha-Chlorohydrin results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Methamphetamine results in increased expression of XBP1 protein alternative form] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of XBP1 protein alternative form]]; 4-phenylbutyric acid affects the reaction [LEPR gene mutant form affects the splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased splicing of XBP1 mRNA]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased expression of XBP1 protein alternative form]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased splicing of XBP1 mRNA] 4-phenylbutyric acid results in decreased expression of XBP1 protein alternative form |
CTD |
PMID:20165829 PMID:23274897 PMID:25295624 PMID:27578021 PMID:27638906 PMID:28245985 PMID:29444456 PMID:30602124 PMID:30796460 PMID:31298478 PMID:33651226 PMID:33771661 PMID:34214594 PMID:35413383 PMID:36670177 PMID:37692514 More...
|
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xpo5 |
exportin 5 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of XPO5 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 9:14,740,182...14,778,171
Ensembl chr 9:14,740,182...14,778,171
|
|
G |
Ythdf2 |
YTH N6-methyladenosine RNA binding protein F2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of YTHDF2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 5:144,381,426...144,407,126
Ensembl chr 5:144,381,431...144,408,144
|
|
G |
Zbtb2 |
zinc finger and BTB domain containing 2 |
decreases expression |
ISO |
4-phenylbutyric acid results in decreased expression of ZBTB2 mRNA |
CTD |
PMID:14583596 |
|
NCBI chr 1:40,827,457...40,846,733
Ensembl chr 1:40,827,457...40,846,594
|
|